Proof-of-concept and Randomized, Placebo-controlled Trials of an FcRn Inhibitor, Batoclimab, for Thyroid Eye Disease.
George J Kahaly, Peter J Dolman, Jan Wolf, Bert C Giers, Heike M Elflein, Amy P Jain, Ashok Srinivasan, Lubomir Hadjiiski, David Jordan, Elizabeth A Bradley, Marius N Stan, Anja Eckstein, Susanne Pitz, Christian Vorländer, Sara T Wester, John Nguyen, Nancy Tucker, Marco Sales-Sanz, Steven E Feldon, Christine C Nelson, Isabelle Hardy, Maravillas Abia-Serrano, Philip Tedeschi, Jonathan M Janes, Jing Xu, Peter Vue, William L Macias, Raymond S Douglas
The Journal of clinical endocrinology and metabolism 2023;108(12):3122-3134